Süleyman Coşgun¹* and Derya Ünal²

¹Kütahya University of Health Sciences, Department of Internal Medicine, Department of Gastroenterology, Turkey
²Kütahya University of Health Sciences, Department of Internal Medicine, Turkey

*Corresponding Author: Süleyman Coşgun, Kütahya University of Health Sciences, Department of Internal Medicine, Department of Gastroenterology, Turkey.

Received: January 27, 2022; Published: April 10, 2022

Abstract

Hepatosteatosis, which we frequently observe today with change in lifestyle, is often unnoticed, but preventable and reversible; if not prevented, it can lead to serious comorbidities. One of the factors causing this condition is insulin resistance during the gestation period and diabetes mellitus, particularly because of excess weight that cannot be lost after pregnancy. There are multiple factors, but we investigate the effect of breastfeeding in the process. This study aims to investigate the effect of breastfeeding on non-alcoholic hepatosteatosis in female patients aged 20-40 years old who have given birth. There is contradicting evidence in the literature; we believe that breastfeeding has a protective effect on hepatosteatosis.

Keywords: Breastfeeding; Body Mass Index; Hepatosteatosis; Fibrosis Score

References

1. AB Engin and A Engin. “Obesity and Lipotoxicity” 960 (2017).
2. E Cobbina and F Akhlaghi. “Non-alcoholic fatty liver disease (NAFLD)-pathogenesis, classification, and effect on drug metabolizing enzymes and transporters”. Drug Metabolism Reviews 2 (2017): 197-211.
3. P Bedossa. “Pathology of non-alcoholic fatty liver disease”. Liver International 2016 (2017): 85-89.
4. M Benedict and X Zhang. “Non-alcoholic fatty liver disease: An expanded review”. World Journal of Hepatology 16 (2017): 715-732.
5. P Stål. “Liver fibrosis in non-alcoholic fatty liver disease-Diagnostic challenge with prognostic significance”. World Journal of Gastroenterology 39 (2015): 11077-11087.
6. G Vernon., et al. “Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults”. Alimentary Pharmacology and Therapeutics 3 (2011): 274-285.
7. YH Lee., et al. “Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)”. Hepatology3 (2016): 776-786.
8. DM Tanase., et al. “The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)” (2020).
9. JG Fan., et al. “New trends on obesity and NAFLD in Asia”. Journal of Hepatology 4 (2017): 862-873.
10. AR Araújo., et al. “Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future”. Liver International 2017 (2018): 47-51.
11. “Obesity and overweight”. WHO (2020).
12. “Prevalence of overweight among adults, BMI and GreaterEqual”. WHO (2017).
13. Z Younossi., et al. “Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention”. Nature Reviews Gastroenterology and Hepatology 1 (2018): 11-20.
14. YH Lee., et al. “Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011)”. Journal of Hepatology 2 (2015): 486-493.
15. G Marchesini., et al. “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”. Journal of Hepatology 6 (2016): 1388-1402.
16. K Dal., et al. “The role of insulin - Like growth factor - 1 on steatohepatitis”. Acta Gastro-Enterologica Belgicag1 (2017): 21-24.
17. W Zhang and L Wei. “Prevalence of nonalcoholic fatty liver disease in Asia”. Zhonghua Gan Zang Bing Za Zhi11 (2013): 801-804.
18. KM Krause., et al. “Effect of breast-feeding on weight retention at 3 and 6 months postpartum: Data from the North Carolina WIC Programme”. Public Health Nutrition 12 (2010): 2019-2026.
19. C Sanna., et al. “Non-alcoholic fatty liver disease and extra-hepatic cancers”. International Journal of Molecular Sciences 5 (2016).
20. GA Kim., et al. “Association between non-alcoholic fatty liver disease and cancer incidence rate”. Journal of Hepatology1 (2018): 140-146.
21. E Vilar-Gomez., et al. “Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: A multi-national cohort study”. Gastroenterology2 (2018): 443-457.
22. H Hagström., et al. “Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD”. Journal of Hepatology 6 (2017): 1265-1273.
23. EP Gunderson., et al. “Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: The SWIFT cohort”. Diabetes Care1 (2012): 50-56.
24. P Wiklund., et al. “Prolonged breast-feeding protects mothers from later-life obesity and related cardio-metabolic disorders”. Public Health Nutrition1 (2012): 67-74.
25. H Kirkegaard., et al. “How do pregnancy-related weight changes and breastfeeding relate to maternal weight and BMI-adjusted waist circumference 7 y after delivery? Results from a path analysis1-3”. The American Journal of Clinical Nutrition 2 (2014): 312-319.
26. JL Baker., et al. “Breastfeeding reduces postpartum weight retention”. The American Journal of Clinical Nutrition 6 (2008): 1543-1551.

Citation

Citation: Süleyman Coşgun and Derya Ünal. “Effect of Breastfeeding Period on Obesity and Hepatosteatosis". Acta Scientific Gastrointestinal Disorders 5.5 (2022): 03-07.

Copyright

Copyright: © 2022 Süleyman Coşgun and Derya Ünal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.